Dose dense chemotherapy might be the only modifiable factor associated with distant recurrence in high-risk patients with endometrial cancer by Matanes, E., Mitric, C., Amajoud, Z., Abitbol, J., Eisenberg, N., Nazer, A., López-Ozuna, V., Yasmeen, A., Salvador, S., Lau, S., Gotlieb, W.H., Kogan, L.

Get full text

Sentinel lymph node sampling is associated with better survival outcome in intermediate-high risk patients with endometrial cancer by Matanes, E., Mitric, C., Amajoud, Z., Abitbol, J., Eisenberg, N., López-Ozuna, V., Yasmeen, A., How, J., Salvador, S., Lau, S., Gotlieb, W.H., Kogan, L.

Get full text

Dose dense carboplatin-paclitaxel improves survival in patients with endometrial cancer: Long term follow-up by Matanes, E., Mitric, C., Amajoud, Z., Abitbol, J., Eisenberg, N., Nazer, A., López-Ozuna, V., Yasmeen, A., Salvador, S., Lau, S., Gotlieb, W.H., Kogan, L.

Get full text

Inhibition of PARG sensitizes ovarian cancer cells to PARP inhibitors and DNA damaging agents by Matanes, E., Kogan, L., López-Ozuna, V., Mitric, C., Raban, O., Eisenberg, N., Baloch, T., Salvador, S., Lau, S., Gotlieb, W.H., Yasmeen, A.

Get full text

Predicting histologic upgrading in endometrial cancer by Matanes, E., Mitric, C., Wissing, M., Amajoud, Z., Abitbol, J., Eisenberg, N., López-Ozuna, V., Raban, O., Yasmeen, A., Salvador, S., Lau, S., Gotlieb, W.H., Kogan, L.

Get full text

Sentinel lymph nodes sampling in patients with high-risk endometrial cancer by Matanes, E., Mitric, C., Wissing, M., Amajoud, Z., Abitbol, J., Eisenberg, N., How, J., López-Ozuna, V., Yasmeen, A., Salvador, S., Lau, S., Gotlieb, W.H., Kogan, L.

Get full text

Prolonged waiting times for surgery in patients with endometrial cancer is associated with lymph-vascular space invasion but has limited effect on clinical outcome by Mitric, C., Wissing, M., Matanes, E., Amajoud, Z., Abitbol, J., Eisenberg, N., López-Ozuna, V., Yasmeen, A., Salvador, S., Lau, S., Gotlieb, W.H., Kogan, L.

Get full text